Literature DB >> 21886303

Breast cancer worry among women awaiting mammography: is it unfounded? Does prior counseling help?

Susan K Steinemann1, Maria B J Chun, Dustin H Huynh, Katherine Loui.   

Abstract

The purpose of this study was to explore the prevalence of breast cancer anxiety and risk counseling in women undergoing mammography, and the association with known risk factors for cancer. Women awaiting mammography were surveyed regarding anxiety, prior breast cancer risk counseling, demographic and risk factors. Anxiety was assessed via 7-point Likert-type scale (LS). Risk was defined by Gail model or prior breast cancer. Data were analyzed by nonparametric methods; significance determined at alpha = 0.05. Of 227 women surveyed, 54 were classified "higher risk". Counseling prevalence was similar (52%) for all ethnic groups, but higher (72%, P<0.001) for "higher risk" women. On average, women awaiting screening/diagnostic mammography were somewhat worried (median LS = 4). Worry was significantly higher (P<0.05) in "higher risk" women (LS = 5), and in women living outside Honolulu (LS = 6). Counseling by primary care physicians (PCP) did not correlate with lower worry scores. It was concluded that most women awaiting mammography are not unduly anxious. Additionally, the findings showed a correlation between a woman's concern about developing cancer with known risk factors and rural residence.

Entities:  

Mesh:

Year:  2011        PMID: 21886303      PMCID: PMC3158373     

Source DB:  PubMed          Journal:  Hawaii Med J        ISSN: 0017-8594


  8 in total

Review 1.  Practical issues in counseling healthy women about their breast cancer risk and use of tamoxifen citrate.

Authors:  H J Smedira
Journal:  Arch Intern Med       Date:  2000-11-13

Review 2.  Putting the risk of breast cancer in perspective.

Authors:  J P Bunker; J Houghton; M Baum
Journal:  BMJ       Date:  1998-11-07

3.  A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use.

Authors:  M D Schwartz; B K Rimer; M Daly; C Sands; C Lerman
Journal:  Am J Public Health       Date:  1999-06       Impact factor: 9.308

Review 4.  The psychological impact of mammographic screening. A systematic review.

Authors:  J Brett; C Bankhead; B Henderson; E Watson; J Austoker
Journal:  Psychooncology       Date:  2005-11       Impact factor: 3.894

Review 5.  Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.

Authors:  Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2010 Mar-Apr       Impact factor: 508.702

6.  Breast cancer worry and screening: some prospective data.

Authors:  K D McCaul; D M Schroeder; P A Reid
Journal:  Health Psychol       Date:  1996-11       Impact factor: 4.267

7.  Breast cancer risk counseling improves women's functioning.

Authors:  Deborah J Bowen; Wylie Burke; Anne McTiernan; Yutaka Yasui; M Robyn Andersen
Journal:  Patient Educ Couns       Date:  2004-04

Review 8.  Cancer risk elicitation and communication: lessons from the psychology of risk perception.

Authors:  William M P Klein; Michael E Stefanek
Journal:  CA Cancer J Clin       Date:  2007 May-Jun       Impact factor: 508.702

  8 in total
  3 in total

Review 1.  Psychological distress associated with cancer screening: A systematic review.

Authors:  Emma Chad-Friedman; Sarah Coleman; Lara N Traeger; William F Pirl; Roberta Goldman; Steven J Atlas; Elyse R Park
Journal:  Cancer       Date:  2017-08-22       Impact factor: 6.860

2.  Effects of Reduced Compression in Digital Breast Tomosynthesis on Pain, Anxiety, and Image Quality.

Authors:  Siti Aishah Abdullah Suhaimi; Afifah Mohamed; Mahadir Ahmad; Kanaga Kumari Chelliah
Journal:  Malays J Med Sci       Date:  2015-11

Review 3.  Scanxiety: a scoping review about scan-associated anxiety.

Authors:  Kim Tam Bui; Roger Liang; Belinda E Kiely; Chris Brown; Haryana M Dhillon; Prunella Blinman
Journal:  BMJ Open       Date:  2021-05-26       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.